The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium

C.A. Wijbrandts, M.G. Dijkgraaf, MC Kraan, M. Vinkenoog, TJ Smeets, H. Dinant, K. Vos, W.F. Lems, G.J. Wolbink, D. Sijpkens, B.A.C. Dijkmans, P.P. Tak

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1139-1144
JournalAnnals of the Rheumatic Diseases
Issue number8
Publication statusPublished - 2008

Cite this